DNA methylation in breast cancer

Endocrine-Related Cancer

Volumn 8, Issue 2, 2001, Pages 115-127

  Yang, X ^a   Yan, L ^a   Davidson, N E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE;

BREAST CANCER; CHROMATIN STRUCTURE; CONFERENCE PAPER; CPG ISLAND; DNA METHYLATION; GENE OVEREXPRESSION; HUMAN; REGULATOR GENE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALS; BREAST NEOPLASMS; CHROMATIN; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS;

EID: 0034947539     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0080115     Document Type: Conference Paper

References (144)

1. Number of CpG islands and genes in human and mouse
2. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggests a suppressor role in kidney, brain, and other human cancers
3. Role of DNA 5-methylcytosine transferase in cell transformation by fos
4. Alterations in DNA methylation: A fundamental aspect of neoplasia
5. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer
6. Cloning of a mammalian DNA methyltransferase
7. Cytosine methylation and the unequal developmental potentials of the oocyte and sperm genomes
8. The DNA methyltransferases of mammals
9. DNA methyltransferases
10. DNA methylation and the frequency of CpG in animal DNA
11. Gene number, noise reduction and biological complexity
12. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors
13. Immunohistochemical demonstration of glutathione S-transferases in primary human breast carcinomas
14. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
15. Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate
16. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: Correlation with disease characteristics
17. Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators
18. DNA methylation and gene activity
19. Short-term culturing of low-grade superficial bladder transitional cell carcinomas leads to changes in the expression levels of several proteins involved in key cellular activities
20. A decade of molecular biology of retinoic acid receptors
21. Relationship between transcription and DNA methylation
22. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage
23. Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1
24. At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer
25. CpG islands and genes
26. Glutathione S-transferases: Gene structure and regulation of expression
27. Combined endocrine therapy for breast cancer - New life for an old idea?
28. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis
29. Chemopreventive efficacy of suberanilohydroxamic acid (SAHA), a cytodifferentiating agent, against tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1 butanone (NNK)-induced lung tumorigenesis in female A/J mice
30. Methylation of the BRCA1 gene in sporadic breast cancer
31. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression
32. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer
33. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia
34. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis
35. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients
36. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
37. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
38. Detection of breast cancer cells in ductal lavage fluid by methylation specific PCR
39. Cancer epigenetics takes center stage
40. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression
41. Role of estrogen receptor gene demethylation and DNA methyltransferase. DNA adduct formation in 5-aza-2′deoxycytidine-induced cytotoxicity in human breast cancer cells
42. Demethylation of the progesterone receptor CpG island is not required for progesterone receptor gene expression
43. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer
44. The role of estrogen in mammary carcinogenesis
45. Loss of the maternal H19 gene induces changes in Igf2 methylation in both cis and trans
46. Inactivation of p16 in human mammary epithelial cells by CpG island methylation
47. Down-regulation of human DNA-(cytosine-5) methyltransferase induces cell cycle regulators p16(ink4A) and p21(WAF/Cip1) by distinct mechanisms
48. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families
49. DNA methyltransferase Dnmt1 associates with histone deacetylase activity
50. Changes in the allelic methylation patterns of c-H-ras-1, insulin and retinoblastoma genes in human development
51. A pilot study of pi-class glutathione S-transferase expression in breast cancer: Correlation with estrogen receptor expression and prognosis in node-negative breast cancer
52. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
53. Expression of metalloproteinases (MMP-1, MMP-2, and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in schistosomal portal fibrosis
54. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
55. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome
56. Role play in X-inactivation
57. X-chromosome inactivation in mammals
58. Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases
59. Promoter-region hypermethylation and gene silencing in human cancer
60. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
61. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
62. Interference with protein binding at AP2 sites by sequence-specific methylation in the late E2A promoter of adenovirus type 2 DNA
63. Mechanisms of inactivation of E-cadherin in breast cancer cell lines
64. Treatment of breast cancer
65. INK4a gene expression and methylation in primary breast cancer: Overexpression of p16INK4a messenger RNA is a marker of poor prognosis
66. The interactions of APC, E-cadherin and beta-catenin in tumour development and progression
67. Increased cytosine DNA-methyltransferase activity during colon cancer progression
68. Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells
69. Human breast carcinoma slice cultures retain retinoic acid sensitivity
70. Effects of 5-azacytidine and its 2′-deoxyderivative on cell differentiation and DNA methylation
71. Cellular differentiation, cytidine analogs and DNA methylation
72. Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells
73. Effect of regional DNA methylation on gene expression
74. Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase
75. Methylation of slipped duplexes, snapbacks and cruciforms by human DNA(cytosine-5)-methyltransferase
76. Methylation of estrogen and progesterone receptor gene 5′CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors
77. Mapping of ER gene CpG island methylation-specific polymerase chain reaction
78. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis
79. De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells
80. Genetic instability in colorectal cancers
81. Genetic instabilities in human cancers
82. 5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia
83. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
84. DNA methylation, genomic imprinting, and mammalian development
85. Role of the p16 tumor suppressor gene in cancer
86. Regional methylation of the 5′ end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells
87. Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer
88. Identification of three classes of cytosolic glutathione transferase common to several mammalian species: Correlation between structural data and enzymatic properties
89. Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells
90. Increased formation of oxidative DNA damage, 8-hydroxy-2′- Deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes
91. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours
92. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
93. Retinoid receptors in health and disease: Co-regulators and the chromatin connection
94. Foreign DNA integration: Genome-wide perturbations of methylation and transcription in the recipient genomes
95. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor
96. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex
97. Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells
98. Aberrant methylation of the estrogen receptor and E-cadherin 5′CpG islands increases with malignant progression in human breast cancer
99. Histone deacetylases: Silencers for hire
100. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex
101. Active repression of methylated genes by the chromosomal protein MBD1
102. Pharmacological manipulation of fetal hemoglobin synthesis in patients with severe beta-thalassemia
103. Correlation between E-cadherin expression and metastasis in human breast cancer: Preliminary report
104. Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells
105. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development
106. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells
107. Baculovirus-mediated expression and characterization of the full-length murine DNA methyltransferase
108. Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide
109. Imprinting mechanisms in mammals
110. CpG methylation is maintained in human cancer cells lacking DNMT1
111. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
112. Mutations of the E-cadherin gene in human gynecologic cancers
113. Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemia
114. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: Coordinate mRNA expression in normal tissues and overexpression in tumors
115. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters
116. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci
117. Hormone dependence of breast cancer cells and the effects of tamoxifen and estrogen: 31P NMR studies
118. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors
119. Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine
120. Involvement of DNA methylation in human carcinogenesis
121. Genomic instability: First step to carcinogenesis
122. The INK4A/ARF locus and its two gene products
123. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells
124. DNA methyltransferase is a downstream effector of cellular transformation triggered by simian virus 40 large T antigen
125. MBDs mediate methylation, deacetylation and transcriptional repression
126. Down-regulation of retinoic acid receptor beta in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells
127. A paternal-specific methylation imprint marks the alleles of the mouse H19 gene
128. Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family
129. Rare bases in animal DNA
130. A multiple subunit Mi-2 histone deacetylase from Xenopus laevis cofractionates with an associated Snf2 superfamily ATPase
131. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase
132. Pharmacogenomics - Teaching old drugs new tricks
133. The role of DNA demethylation during development
134. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer
135. Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer
136. DNA methylation in the promoter region of the p16 (CDKN2/MTS-1/INK4A) gene in human breast tumours
137. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells
138. Cloning, expression and chromosome locations of the human DNMT3 gene family
139. Endogenous estrogens as carcinogens through metabolic activation
140. Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition
141. Synergistic reactivation of functional estrogen receptor by DNMT1 and HDAC inhibition in human breast cancer cells
142. Isolation and characterization of the cDNA encoding human DNA methyltransferase
143. Cytosine methylation and the ecology of intragenomic parasites
144. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A